Abstract | BACKGROUND: OBJECTIVE: METHODS: RESULTS: During the 3-month trial, the condition of all 12 patients showed statistically significant improvement in all studied features. No adverse effects were reported or detected through laboratory monitoring of mineral metabolism. CONCLUSION:
|
Authors | B B Cunningham, I D Landells, C Langman, D E Sailer, A S Paller |
Journal | Journal of the American Academy of Dermatology
(J Am Acad Dermatol)
Vol. 39
Issue 2 Pt 1
Pg. 211-5
(Aug 1998)
ISSN: 0190-9622 [Print] United States |
PMID | 9704831
(Publication Type: Case Reports, Clinical Trial, Journal Article)
|
Chemical References |
- Dermatologic Agents
- Ointments
- calcipotriene
- Calcitriol
|
Topics |
- Administration, Topical
- Adolescent
- Calcitriol
(administration & dosage, adverse effects, analogs & derivatives)
- Child
- Dermatologic Agents
(administration & dosage, adverse effects)
- Female
- Humans
- Male
- Ointments
- Scleroderma, Localized
(drug therapy, metabolism)
- Time Factors
|